Technology Transfer Tactics is pleased to present a new line of research reports, published by our partner Business Insights, a world leader in strategic market analysis. Business Insights‘ portfolio of reports is designed to help you make well-informed and timely business decisions. With an understanding of problems facing today’s research commercialization professionals and executives, Business Insights helps you crystallize your strategic planning and drive your organization forward.

Available reports:
Check back often as more reports will be added

• The Funding Landscape for Small Biopharma Ventures, 2010-2015: Trends, strategies and priorities
• Drug Discovery Collaborations between Academia and the Pharmaceutical Industry
• Building Biotech Technology Transfer Opportunities
• Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
• Technology Transfer Strategies: Maximizing the returns from new technologies
• Evolving Trends in Biopharmaceutical Licensing: Deal assessments, drivers and resistors
• Patent Protection Strategies: Maximising product Revenues
• Biotech Exit Strategies: Delivering value to investors in a challenging funding market
• Innovations in Protein Kinase Therapies: Company pipelines, therapeutic applications and market forecasts
• Innovative Strategies and Models for R&D Success: The evolving networked pharma company
• The Autoimmune Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
• The Top 10 Contract Research Organizations: Positioning, performance and SWOT analyses
• Key Players in Pharmaceutical Contract Manufacturing: Market developments, outsourcing hotspots and growth strategies
• Innovation in Weight Management: Novel ingredients, regulatory challenges and go-to-market strategies
• Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success
• Leading Fuel Cell Technologies: Applications, costs, economic competitiveness and future prospects